# A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors

> **NCT04791228** · PHASE2 · WITHDRAWN · sponsor: **Children's National Research Institute**

## Conditions studied

- Solid Tumors
- Soft Tissue Sarcoma
- Ewing Sarcoma
- Malignant Epithelial Neoplasm
- Rhabdomyosarcoma
- Wilms Tumor
- Hepatic Tumor
- Germ Cell Tumor
- Bone Metastases

## Interventions

- **DEVICE:** Magnetic Resonance-Guided High Intensity Focused Ultrasound
- **DRUG:** Lyso-thermosensitive Liposomal Doxorubicin

## Key facts

- **NCT ID:** NCT04791228
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-11-10
- **Primary completion:** 2024-12-23
- **Final completion:** 2024-12-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Low enrollment.
- **Last updated:** 2025-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791228, "A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04791228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*